Actually, patients with deficient Nox2 activity due to mutations in oxidase subunits suffer from chronic granulomatous disease (CGD), a condition in which there is increased susceptibility to bacterial and fungal infections1. The gene discussed is CYBB; the disease is chronic granulomatous disease.